COVID-19 testing in India: DCGI gives approval to commercial launch of low-cost ‘Feluda’ test

The test makes use of an indigenous, “cutting-edge” CRISPR technologyCOVID-19 testing: Tata CRISPR low-cost COVID-19 test’s commercial launch approved! The Drugs Controller General of India (DCGI) on Saturday approved ‘Feluda’,…

Continue ReadingCOVID-19 testing in India: DCGI gives approval to commercial launch of low-cost ‘Feluda’ test